Unity Biotechnology, Inc.
UBX · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $18 | $16 | $25 | $22 |
| - Cash | $8 | $8 | $9 | $8 |
| + Debt | $23 | $24 | $21 | $22 |
| Enterprise Value | $32 | $32 | $37 | $36 |
| Revenue | $0 | $1 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | -$0 | $1 | -$0 | -$0 |
| % Margin | – | 50% | – | – |
| EBITDA | -$7 | -$8 | -$6 | -$5 |
| % Margin | – | -620.3% | – | – |
| Net Income | -$7 | -$8 | -$6 | -$5 |
| % Margin | – | -635.5% | – | – |
| EPS Diluted | -0.43 | -0.5 | -0.38 | -0.31 |
| % Growth | 14% | -31.6% | -22.6% | – |
| Operating Cash Flow | -$6 | -$6 | -$5 | -$5 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$6 | -$6 | -$5 | -$5 |